Diabetes Care 40(11):15881596 Lee DSU, Lee H (2022) Adherence and persistence rates of major antidiabetic medications: a review
Efficacy and safety of cAMP-biased GLP-1 receptor agonist ecnoglutide versus dulaglutide in patients with type 2 diabetes and elevated glucose concentrations on metformin monotherapy (EECOH-2): a 52-week, multicentre, open-label, non-inferiority, randomised, phase 3 trial
People usually lose about 2% of their body weight in the first month of taking semaglutide
Aim for at least 150 minutes of moderate-intensity exercise per week, or 75 minutes of vigorous-intensity exercise, spread out over several days
Some studies even reported lower incidence of cancer, including colorectal, liver, prostate and endometrial cancers, said Wellberg, an assistant professor in the OU College of Medicine and research member of OU Health Stephenson Cancer Center
Connect with a Mochi Health provider for tailored guidance from an obesity medicine specialist